Clinical & Diagnostic
CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China
Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...
October 17, 2023 | News
TaiMed Reports Major Advances in Clinical Trials for New HIV Treatment in Taiwan
TaiMed Biologics, an innovation-driven biotech company dedicated to serving unmet healthcare needs, has announced favorable results and the successful comp...
October 17, 2023 | News
Adalvo and Eurolab strengthen Strategic Partnership in South Africa and SSA Regions
These value-added products encompass a diverse range of segments, each catering to specific indications and fulfilling unique patient needs. The portfolio ...
October 16, 2023 | News
AbbVie's SKYRIZI® Outperforms STELARA® in Crohn's Disease Study
SEQUENCE, a Phase 3 head-to-head study, compared risankizumab to ustekinumab for the treatment of adult patients with moderately to severely active ...
October 16, 2023 | News
Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
Nona Biosciences and INGENIA Therapeutics Join Forces for Immunology Breakthroughs
By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for im...
October 16, 2023 | News
CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
October 13, 2023 | News
Metabolon Introduces Liver and Kidney Panels for Disease Research
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
October 13, 2023 | News
MediLink and BioNTech Partner for Advanced Anti-Cancer Drug
Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...
October 13, 2023 | News
EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand
EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...
October 12, 2023 | News
Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test
This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...
October 12, 2023 | News
Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.
In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...
October 11, 2023 | News
LGC Acquires Virusys Corp, Expanding Infectious Disease Portfolio
Virusys’ monoclonal antibody technologies and virology expertise are highly complementary to LGC Clinical Diagnostics’ existing antigen product...
October 10, 2023 | News
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...
October 10, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
